April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 21, 2025

New Findings Show No Difference in IGE Treatment Strategies

A study found no statistically significant differences in treatment failure rates between substitution monotherapy and add-on therapy for women with idiopathic generalized epilepsy, indicating both options are viable.

Conexiant

April 18, 2025

Vaccination May Lower RA Risk

Researchers found no increased risk of rheumatoid arthritis following vaccination. In fact, they observed short-term protective effects against RA.

Conexiant

April 17, 2025

Phase 3 Trial Supports New Gonorrhea Drug

Trial shows oral gepotidacin is non-inferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 09, 2025

22 Drugs Tied to Melasma

Researchers identified 22 drugs, primarily hormonal agents, associated with melasma.

Conexiant

April 09, 2025

Twins Grow Differently: Fat Tissue Trends Start Early

Study reveals twin fetuses accumulate significantly less fat tissue than singletons as early as 15 weeks, suggesting an evolutionary adaptation rather than pathological growth restriction.

Conexiant

April 07, 2025

Pulse Oximeter Bias in ICU Patients?

Pulse oximetry may be unreliable in diverse patient populations.

Conexiant

April 02, 2025

HPV Testing Guidelines Updated for Head and Neck Carcinomas

New evidence expands recommendations for sinonasal squamous cell carcinoma and standardizes p16 immunohistochemistry interpretation.

Conexiant